News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Yamanouchi Pharmaceutical Co., Ltd., Fujisawa Pharmaceutical Co., Ltd. To Become Astellas Post-Merger; $7.12 Billion


10/19/2005 5:11:29 PM

Japan's Yamanouchi Pharmaceutical (4503.T: Quote, Profile, Research) and Fujisawa Pharmaceutical (4511.T: Quote, Profile, Research) said on Monday they had completed the terms of their planned merger and the new company would be called Astellas.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES